Press release
Acute Renal Failure Market Growth, Trends & Key Players 2024 | Novartis, Amgen, Roche.
Acute Renal Failure Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/acute-renal-failure-market?sz
The Global Acute Renal Failure Market reached US$ 5.30 million in 2023 and is expected to reach US$ 11.02 million by 2031, growing at a CAGR of 9.0% during the forecast period 2024-2031.
The Acute Renal Failure Market focuses on treatments and therapies for acute kidney injury (AKI), a condition where the kidneys suddenly lose their ability to filter waste. The market includes pharmaceuticals, dialysis solutions, and emerging treatments like kidney regeneration therapies. Growing incidences of kidney diseases, increased awareness, and advancements in treatment options are propelling market growth in both developed and emerging regions.
Transform your pharma strategy with expert insights and competitive analysis: https://www.datamintelligence.com/competitive-intelligence/contact
List of the Key Players in the Acute Renal Failure Market:
Novartis, Fresenius Medical Care, Amgen, Roche, Baxter International Inc, Zypharma, Nature Made, Pfizer, GSK, and Eli Lilly among others.
Market Dynamics:
Rise in the prevalence of kidney diseases
The rising incidence of acute renal failure (ARF) is significantly impacting the treatment market, driven by factors such as chronic diseases, aging populations, and advances in diagnostic technology. As a result, there's a growing demand for effective treatment options.
For example, an article from NCBI highlights that acute renal failure is commonly observed in hospitalized patients. In the U.S., around 1% of all hospital admissions involve acute kidney injury (AKI) upon admission. During hospitalization, AKI occurs in approximately 2% to 5% of cases, and up to 67% of patients in intensive care units are affected. This makes AKI a key factor in longer hospital stays and increased patient morbidity.
Growth Forecast Projected:
The Global Acute Renal Failure Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Acute Renal Failure Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/acute-renal-failure-market
Segment Covered in the Acute Renal Failure Market:
By Disease Type: Prerenal Acute Renal Failure, Renal Acute Renal Failure, Postrenal Acute Renal Failure.
By Drug Type: Diuretics, Vasopressors, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Calcium and Vitamin D Supplements, Antibiotics, Others.
By Route of Administration: Oral, Intravenous.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Regional Analysis for Acute Renal Failure Market:
The regional analysis of the Acute Renal Failure Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/acute-renal-failure-market
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Acute Renal Failure market?
➠ Who are the leading manufacturers in the global Acute Renal Failure industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Acute Renal Failure industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Acute Renal Failure market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Renal Failure Market Growth, Trends & Key Players 2024 | Novartis, Amgen, Roche. here
News-ID: 3871778 • Views: …
More Releases from DataM Intelligence 4Market Research

CAR-T Cell Therapy Market Growth | Emerging Trends, Key Players & Future Outlook …
The Global CAR-T cell therapy market reached US$ 4.8 billion in 2024 and is expected to reach US$ 20.4 billion by 2033, growing at a CAGR of 16.3% during the forecast period 2025-2033.
CAR-T Cell Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…

Cell and Gene Therapy Market: Rising Demand, Innovative Therapies & Growth Trend …
The Global Cell and Gene Therapy Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Cell and Gene Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research…

Mineral Oils Market Growth | Trends, Demand & Future Forecast 2024-2031 | Top ke …
The Global Mineral Oils Market reached US$ 5.1 billion in 2022 and is expected to reach US$ 7.1 billion by 2030, growing with a CAGR of 4.2% during the forecast period 2024-2031.
Mineral Oils Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of…

Emulsifiers Market Growth | Trends, Demand & Forecast 2024-2031 | Top key player …
The Global Emulsifiers Market reached US$ 3.4 billion in 2022 and is expected to reach US$ 5.0 billion by 2030 growing with a CAGR of 4.9% during the forecast period 2024-2031.
Emulsifiers Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition.…
More Releases for Renal
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period…
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report…
Renal Insufficiency Market Vendor Growth Landscape 2025
Global Renal Insufficiency Market: Snapshot
The demand for renal disease treatment products and therapies has been incrementing steadily in the past few years, owing to the prevalence of poor kidney functions among a vast population base across the world, especially in the Asia Pacific region, and increased government support. However, the participants of the global renal insufficiency market must take a note of weak competition among the marketed products for the…
Acute Renal Failure - Pipeline Review, H1 2018
"The Report Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
About Acute Renal Failure Market
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)…
Acute Renal Failure Epidemiology Insights to 2025
Publisher " Acute Renal Failure ARF Acute Kidney Injury - Epidemiology Forecast To 2025" provides an overview of the epidemiology trends of Acute Renal Failure ARF Acute Kidney Injury in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Acute Renal Failure ARF Acute Kidney Injury prevalent or incident cases segmented by age, sex and subpopulations. The Report…
Renal Cluster Drug Development Pipeline Review, 2017
ReportsWorldwide has announced the addition of a new report title
Renal Cluster Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports.
This report provides an overview of the renal cluster pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Kidney Fibrosis, Chronic Kidney Disease (Chronic Renal Failure), Acute Renal Failure (ARF), Kidney Transplant Rejection, and…